Abstract:Topical therapies for chronic skin diseases suffer from a low patient compliance due to the inconvenient treatment regimens of available products. Dissolvable microneedles (MN) with modified release offer an interesting possibility to increase the compliance by acting as a depot in the skin and thereby decreasing the dosing frequency. Furthermore, the bioavailability can be increased significantly by bypassing the barrier of the skin by the direct penetration of the MN into the skin. In this study the depot effect and skin penetration of an innovative dissolvable MN patch was assessed by insertion in ex vivo human skin and in vivo using minipigs. The MN patches are based on biodegradable polymers and the active pharmaceutical ingredients calcipotriol (Calci) and betamethasone-17-21-dipropionate (BDP) used to treat psoriasis. Using computed tomography (CT) and Coherent anti-Stokes Raman scattering (CARS) microscopy it was possible to visualize the skin penetration and follow the morphology of the MN as function of time in the skin. The depot effect was assessed by studying the modified in vitro release in an aqueous buffer and by comparing the drug release of a single application of a patch both ex vivo and in vivo to daily application of a marketed oleogel containing the same active pharmaceutical ingredients. The CT and CARS images showed efficient penetration of the MN patches into the upper dermis and a slow swelling process of the drug containing tip over a period of 8 days. Furthermore, CARS demonstrated that it can be used as a noninvasive technique with potential applicability in clinical settings. The in vitro release studies show a release of 54% over a time period of 30 days. The pharmacological relevance of MNs was confirmed in human skin explants and in vivo after single application and showed a similar response on calcipotriol and BDP mediated signaling events compared to daily application of the active oleogel. Altogether it was demonstrated that the MN can penetrate the skin and have the potential to provide a depot effect.

Tissue Distribution and Dermal Drug Determination of Indomethacin Transdermal-Absorption Patches

Design and evaluation of a drug-in-adhesive patch for the transdermal delivery of ketoprofen

Hyaluronan-modified transfersomes based hydrogel for enhanced transdermal delivery of indomethacin

Energy-Dependent Endocytosis Is Responsible for Skin Penetration of Formulations Based on a Combination of Indomethacin Nanoparticles and L-Menthol in Rat and Göttingen Minipig

Physicochemical Characterization, in Vitro, and in Vivo Evaluation of Indomethacin-Loaded Nanocarriers Self-Assembled by Amphiphilic Polyphosphazene.

Single- and Multiple-Dose Pharmacokinetics of a Novel Tetramethylpyrazine Reservoir-Type Transdermal Patch Versus Tetramethylpyrazine Phosphate Oral Tablets in Healthy Normal Volunteers, and in Vitro/in Vivo Correlation.

Development, Characterization, and Cellular Toxicity Evaluation of Solid Dispersion-Loaded Hydrogel Based on Indomethacin

Local Delivery of Indomethacin to Arthritis-Bearing Rats through Polymeric Micelles Based on Amphiphilic Polyphosphazenes

Study on Viscomate NP-800 Based Hydrogel Patch of Indometacin

Benefits of topical indigo naturalis nanofibrous patch on psoriatic skin: A transdermal strategy for botanicals

[Comparison of Concentration of Piroxicam in Blood and Local Site after Two Routes of Administration].

Study of the Percutaneous Permeability of Clonidine Transdermal Patch in Vitro

Preparation and relative bioavailability in rabbits of piroxicam transdermal patch

Development and evaluation of reservoir transdermal polymeric patches for controlled delivery of diclofenac sodium

Dissolvable microneedles for transdermal drug delivery showing skin pentation and modified drug release

A sensitive LC-MS/MS method for quantifying capsaicin and dihydrocapsaicin in rabbit plasma and tissue: application to a pharmacokinetic study

Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch

[Tissue Distribution and Excretion of 5-Fluorouracil from Indomethacin 5-Fluorouracil-1-ylmethylester in Rats].

Pharmacokinetics Of Indomethacin, A Metabolite Of Acemetacin, Following A Single Dose And Multiple Doses Administered As Acemetacin Sustained-Release Tablets In Healthy Male Volunteers

Investigation on Rectal Absorption of Indomethacin from Sustained-Release Hydrogel Suppositories Prepared with Water-Soluble Dietary Fibers, Xanthan Gum and Locust Bean Gum.

Drug Release Test to Assess Quality of Topical Formulations in Japanese Market